studies animals shown newly developed drug cure colon cancer disease effective chemotherapy the research team led dr beppino c giovanella stehlin foundation cancer research houston predicted human tests drug could begin little year colon cancer strikes one 25 americans estimated 107000 per year according american cancer society 53500 victims die year colon cancer third incidence behind lung breast tumors number deaths second lung cancer the effective treatment surgery radiation colon cancer caught early localized stage fiveyear survival rate 87 but cancer spreads detected survival rate plunges 40 the new drug called 9ac derivative camptothecin first isolated chinese ornamental tree called camptotheca acuminata in early 1970s camptothecin tested humans advanced form gastrointestinal cancer the drug produced partial remissions patients trials halted drugs lifethreatening side effects especially leukopenia sharp decrease number diseasefighting white cells researchers remained interested camptothecin however unusual mechanism action it inhibits enzyme known topoisomerase i crucial replication dna deoxyribonucleic acid genetic blueprint life multiplication cells in normal human cell extremely long strands dna coiled tightly inside structures called chromosomes before dna copied reproduction must uncoiled new dna irretrievably tangled old topoisomerase i uncoils cancer researchers excited discovery topoisomerase i offers new point reproductive cycle cancer cells attacked and enzyme uncoils dna researchers believe cells unable circumvent blocked enzyme thereby develop resistance drug studies also shown colon tumor cells abovenormal concentrations topoisomerase i giovanella colleagues administered 9ac synthesized chemist monroe e wall research triangle institute north carolina 50 immunodeficient mice human colon tumors implanted the group reported last week journal science treatment one mice showed complete remission tumors furthermore drug produced adverse side effects in contrast 50 mice received tumors drug died in 20 years experimenting human colon cancers laboratory never seen type dramatic response said dr john stehlin scientific director stehlin foundation experts cautioned however many anticancer drugs found promising animals effective humans